News

RANDY PAUSCH: HIS LAST LECTURE AND FAMOUS QUOTES

July 4, 2017

A Pancreatic Cancer Clinical Trial Shows An Experimental Drug’s Ability To Knock Down the Cancer’s Defense

June 28, 2017

Combined Molecular Biology Test: The First To Identify Patients With Completely Benign Pancreas Abnormalities

June 28, 2017

STUDY: PARTIALLY REDUCING OR INACTIVATING THE GRP78 PROTEIN BY THERAPEUTIC AGENTS MAY BE A SECRET TO COMBATING PANCREATIC CANCER

May 26, 2017

TGen and HonorHealth Research Institute Clinical Trial Report High Rate of Tumor Shrinkage Among Patients With Advanced Pancreatic Cancer

May 18, 2017

Dr. Daniel Von Hoff, TGen ‘s World Renowned Physician-in-Chief Honored By Columbia University For Excellence in Clinical Medicine

May 10, 2017

STUDY SHOWS ‘SOFTENING’ OF PANCREATIC CANCER TUMORS BEFORE CHEMO MARKEDLY IMPROVES PATIENT SURVIVAL

April 13, 2017

SCIENTISTS AT TEL AVIV UNIVERSITY DISCOVER MECHANISM THAT CAUSES CANCER CELLS TO SELF-DESTRUCT

March 30, 2017

LIGHT SCATTERING TOOL HELPS DOCTORS IDENTIFY EARLY PANCREATIC CANCER

March 20, 2017

TWO MIGRATION PROTEINS BOOST PREDICTIVE PANCREATIC CANCER BIOMARKER

March 13, 2017

OUR GOAL IS TO TRIPLE THE AVERAGE 5-YEAR PANCREATIC CANCER SURVIVAL RATE

March 5, 2017

DISCOVERY OF DISTINCT CELL SUB-TYPES AROUND TUMORS HELPS EXPLAIN WHY PANCREATIC CANCER IS SO HARD TO TREAT

March 5, 2017

Study Suggests Controlling Genes Which Lead To Metastatic Pancreatic Cancer May Stop The Cancer From Spreading

March 1, 2017

TYPE 2 ONSET DIABETES CAN BE AN EARLY WARNING SIGN OF PANCREATIC CANCER

February 27, 2017

“Pursuing The Scar”: Latest State of Pancreatic Cancer Research By Dr. Daniel Von Hoff

January 17, 2017

2,100 Oncologists Already Trained Under TGen’s Dr. Daniel Von Hoff. $1.125 Million Granted By NCI For TGen Led Boot Camp For Cancer Doctors

December 13, 2016

Personalized Precision Medicine Unleashed

December 8, 2016

City of Hope and Translational Genomics Research Institute (TGen) Combine To Advance Precision Medicine and Speed of Research

December 5, 2016

TGen’s Dr. Von Hoff is Named a “Giant of Cancer Care”

November 14, 2016

TGen Discovers Potential Drug Targets to Reduce Pancreatic Pain

November 8, 2016

Ambry Genetics and Nationwide Collaborators Begin Prospective Multi-Site Study to Identify Hereditary Pancreatic Cancer

November 3, 2016

New Immunotherapy Treatment Could Lead to Better Treatment of Advanced Pancreatic Cancer

September 19, 2016

Virginia Mason Offers “Game Changer” Surgery To Remove Cancer From Pancreas

September 14, 2016

Getting Pancreatic Cancer is Mostly Random Bad Luck of Cell Mutations

September 14, 2016